1. Home
  2. NKSH vs STXS Comparison

NKSH vs STXS Comparison

Compare NKSH & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NKSH

National Bankshares Inc.

HOLD

Current Price

$33.60

Market Cap

185.2M

Sector

Finance

ML Signal

HOLD

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$2.37

Market Cap

210.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKSH
STXS
Founded
1891
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
185.2M
210.0M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
NKSH
STXS
Price
$33.60
$2.37
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
13.0K
471.8K
Earning Date
01-22-2026
11-11-2025
Dividend Yield
4.50%
N/A
EPS Growth
41.35
N/A
EPS
2.04
N/A
Revenue
$51,980,000.00
$30,075,000.00
Revenue This Year
$2.95
$24.48
Revenue Next Year
$9.97
$29.98
P/E Ratio
$16.43
N/A
Revenue Growth
19.63
19.62
52 Week Low
$23.75
$1.54
52 Week High
$33.92
$3.59

Technical Indicators

Market Signals
Indicator
NKSH
STXS
Relative Strength Index (RSI) 73.37 44.44
Support Level $29.79 $2.34
Resistance Level $30.72 $2.44
Average True Range (ATR) 0.92 0.10
MACD 0.40 0.03
Stochastic Oscillator 96.46 55.17

Price Performance

Historical Comparison
NKSH
STXS

About NKSH National Bankshares Inc.

National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: